Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: moxa1

RE: moxa1

posted on May 02, 2006 05:55AM
I beg to differ, any disbursement is charged as received, and this is part of the problem in evaluating a realistic P/E.

If lump sum payments are so beneficial, why do all the major patent holders charge ongoing royalties?

Be well

Share
New Message
Please login to post a reply